73 related articles for article (PubMed ID: 21325218)
21. New strategy for allotransplantation.
Granstein RD
Lancet; 1996 Sep; 348(9031):838-9. PubMed ID: 8826805
[No Abstract] [Full Text] [Related]
22. Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockade.
Elwood ET; Larsen CP; Cho HR; Corbascio M; Ritchie SC; Alexander DZ; Tucker-Burden C; Linsley PS; Aruffo A; Hollenbaugh D; Winn KJ; Pearson TC
Transplantation; 1998 Jun; 65(11):1422-8. PubMed ID: 9645796
[TBL] [Abstract][Full Text] [Related]
23. Role of nuclear factor of activated T cell (NFAT) transcription factors in skin and vascularized cardiac allograft rejection.
Ueno T; Yamada A; Ito T; Yeung MY; Gorbatov R; Shimizu T; Abdi R; Sayegh MH; Auchincloss H; Najafian N
Transplantation; 2011 Sep; 92(5):e26-7. PubMed ID: 21866037
[No Abstract] [Full Text] [Related]
24. Alloantibodies prevent the induction of transplantation tolerance by enhancing alloreactive T cell priming.
Burns AM; Chong AS
J Immunol; 2011 Jan; 186(1):214-21. PubMed ID: 21135169
[TBL] [Abstract][Full Text] [Related]
25. Effects of T cell frequency and graft size on transplant outcome in mice.
He C; Schenk S; Zhang Q; Valujskikh A; Bayer J; Fairchild RL; Heeger PS
J Immunol; 2004 Jan; 172(1):240-7. PubMed ID: 14688331
[TBL] [Abstract][Full Text] [Related]
26. Epidermal Langerhans cells promote skin allograft rejection in mice with NF-kappa B-impaired T cells.
Molinero LL; Zhou P; Wang Y; Harlin H; Kee B; Abraham C; Alegre ML
Am J Transplant; 2008 Jan; 8(1):21-31. PubMed ID: 18021281
[TBL] [Abstract][Full Text] [Related]
27. Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection.
Jones ND; Turvey SE; Van Maurik A; Hara M; Kingsley CI; Smith CH; Mellor AL; Morris PJ; Wood KJ
J Immunol; 2001 Feb; 166(4):2824-30. PubMed ID: 11160350
[TBL] [Abstract][Full Text] [Related]
28. The role of CD30 in skin and heart allograft rejection in the mouse.
Beckmann J; Kurts C; Klebba I; Bayer B; Klempnauer J; Hoffmann MW
Transplant Proc; 2001; 33(1-2):140-1. PubMed ID: 11266747
[No Abstract] [Full Text] [Related]
29. Second-set rejection of skin allografts is mediated by a T cell subset in mice unable to mount a humoral response with cytotoxic antibodies.
Yoshimura R; Touraine JL; Chargui J; Veyron P; Aitouche A
Transplant Proc; 1997; 29(1-2):868. PubMed ID: 9123560
[No Abstract] [Full Text] [Related]
30. Tolerance to noninherited maternal MHC antigens in mice.
Andrassy J; Kusaka S; Jankowska-Gan E; Torrealba JR; Haynes LD; Marthaler BR; Tam RC; Illigens BM; Anosova N; Benichou G; Burlingham WJ
J Immunol; 2003 Nov; 171(10):5554-61. PubMed ID: 14607963
[TBL] [Abstract][Full Text] [Related]
31. The role of the donor's and recipient's metabolic statuses in successful transplantation of a whole skin graft.
Shumakov VI; Vasilenko VT; Gasanov EK; Piruzyan LA; Saprin AN; Sukhanov VA
Dokl Biol Sci; 2003; 388():35-7. PubMed ID: 12705125
[No Abstract] [Full Text] [Related]
32. B lymphocytes differentially influence acute and chronic allograft rejection in mice.
DiLillo DJ; Griffiths R; Seshan SV; Magro CM; Ruiz P; Coffman TM; Tedder TF
J Immunol; 2011 Feb; 186(4):2643-54. PubMed ID: 21248259
[TBL] [Abstract][Full Text] [Related]
33. Donor cardiac allografts from p53 knockout mice exhibit apoptosis-independent prolongation of survival.
Kown MH; Murata S; Jahncke CL; Mari C; Berry GJ; Lijkwan MA; Blankenberg FG; Strauss HW; Robbins RC
Transplant Proc; 2002 Dec; 34(8):3274-6. PubMed ID: 12493444
[No Abstract] [Full Text] [Related]
34. Vigorous allograft rejection in the absence of danger.
Bingaman AW; Ha J; Waitze SY; Durham MM; Cho HR; Tucker-Burden C; Hendrix R; Cowan SR; Pearson TC; Larsen CP
J Immunol; 2000 Mar; 164(6):3065-71. PubMed ID: 10706695
[TBL] [Abstract][Full Text] [Related]
35. Induction of long-term heart graft survival by intrathymic injection of HLA class I peptide: a study with HLA class I transgenic mice model.
Ando Y; Beck Y; Nakayama S; Asami A; Nomura Y; Tomikawa S; Takiguchi M
Transplant Proc; 2000 Nov; 32(7):2049-50. PubMed ID: 11120061
[No Abstract] [Full Text] [Related]
36. Relationship between leukocytic infiltration and endothelial specialization in murine cardiac allografts.
Leppink DM; Bishop DK; Sedmak DD; Orosz CG
Hum Immunol; 1990 Dec; 29(4):247-55. PubMed ID: 2286537
[TBL] [Abstract][Full Text] [Related]
37. Different role of cyclophosphamide-induced tolerance in heart and skin allograft tolerance.
Iwai T; Tomita Y; Shimizu I; Zhang Q; Okano S; Minagawa R; Nomoto K; Yasui H
Transplant Proc; 2001; 33(1-2):173-5. PubMed ID: 11266765
[No Abstract] [Full Text] [Related]
38. A key role for TGF-beta signaling to T cells in the long-term acceptance of allografts.
Daley SR; Ma J; Adams E; Cobbold SP; Waldmann H
J Immunol; 2007 Sep; 179(6):3648-54. PubMed ID: 17785800
[TBL] [Abstract][Full Text] [Related]
39. Rejection of primarily vascularized heart grafts. III. Depression of the interleukin 2 mechanism early after grafting.
Burdick JF; Clow LW
Transplantation; 1990 Sep; 50(3):476-81. PubMed ID: 2144924
[TBL] [Abstract][Full Text] [Related]
40. Drug-induced tolerance to allografts in mice. V. Prolongation of skin graft survival in tolerant mice with combined immunosuppressive treatments.
Mayumi H; Kayashima K; Shin T; Nomoto K
Transplantation; 1985 Mar; 39(3):335-7. PubMed ID: 3883603
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
